Abstract

INTRODUCTION: Heart failure occurs in 3-4% of adults aged over 65 years, usually as a consequence of coronary artery disease or hypertension, and causes breathlessness, effort intolerance, fluid retention, and increased mortality. The 5-year mortality in people with systolic heart failure ranges from 25-75%, often due to sudden death following ventricular arrhythmia. Risks of cardiovascular events are increased in people with LVSD or heart …

Authors

McKelvie RS

Journal

Clinical evidence, Vol. 2007, ,

ISSN

1462-3846

Associated Experts

Robert McKelvie

Professor Emeritus, Faculty of Health Sciences

Visit profile

Labels

Fields of Research (FoR)

32 Biomedical and Clinical Sciences 3202 Clinical sciences

Medical Subject Headings (MeSH)

Heart Failure United States Adrenergic beta-Antagonists Angiotensin-Converting Enzyme Inhibitors Anti-Arrhythmia Agents Aspirin Calcium Channel Blockers Cardiotonic Agents Defibrillators, Implantable Digoxin Exercise Humans Mineralocorticoid Receptor Antagonists Platelet Aggregation Inhibitors Spironolactone Warfarin